These press releases are intended for business journalists and analysts/investors
GSK advises supply of new quadrivalent (four-strain) influenza vaccine, Fluarix® Tetra, recently launched in Australia and available for private sale, is no longer available for the remainder of the 2015 influenza season due to high levels of demand.
Read more - Supply update: Fluarix Tetra and Fluarix Read more
In 2014, GSK Australia made payments totalling $3,466,951 to healthcare professionals (HCPs) and health-related organisations (HCOs) for grants, sponsorships and consultancy fees related to chairing and speaking at meetings, assistance with training and participation in advisory boards.
Read more - GSK discloses payments to Australian healthcare professionals in 2014 Read more
Learn more about how we are making our vaccines more accessible in developing countries
More children from the world’s poorest countries are being vaccinated against more diseases than ever before.
GSK provides £50,000 donation to Save the Children to support relief efforts following Tropical Cyclone Pam.
Read more - GSK responds to devastation in Vanuatu Read more
GlaxoSmithKline plc (LSE/NYSE: GSK) announces that its three-part transaction with Novartis has completed today.
Read more - GSK completes major three-part transaction with Novartis Read more
MELBOURNE, AUSTRALIA and MUMBAI, INDIA, 3 March, 2015 - GlaxoSmithKline (GSK) and Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE:524715, “Sun Pharma”) today announced that their respective wholly owned subsidiaries have reached an agreement related to GSK’s Opiates business in Australia.
Read more - Sun Pharma to buy GSK’s Opiates business in Australia Read more
Regrettably, Zovirax Ophthalmic Ointment (aciclovir 3%) continues to be impacted by a global supply constraint and is unlikely to be available in Australia prior to September 2015.
Read more - Supply update: Zovirax Ophthalmic Ointment (aciclovir 3%) Read more
More children from the world’s poorest countries are being vaccinated against more diseases than ever before. This is a good thing and has been made possible by unprecedented cooperation between governments, NGOs and pharmaceutical companies.
Read more - GSK statement on affordability of vaccines in developing countries Read more
GSK has responded to the South Australian bushfire emergency by providing eight pharmacies in the Adelaide Hills fire affected areas with a donation of asthma rescue medicine. This donation is being managed in partnership with Asthma Foundation SA and the Pharmacy Guild of Australia.
Read more - Adelaide Hills Bushfires: Donation of asthma medication Read more
- Reimbursed via the Pharmaceutical Benefits Scheme from 1st December
2014
- Administered using a new dry powder inhaler called Ellipta1